S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
Is This The End of Capitalism? (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Cassava Sciences Stock Undervalued with Its $124 Price Target?
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
Is This The End of Capitalism? (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Cassava Sciences Stock Undervalued with Its $124 Price Target?
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
Is This The End of Capitalism? (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Cassava Sciences Stock Undervalued with Its $124 Price Target?
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
Is This The End of Capitalism? (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Cassava Sciences Stock Undervalued with Its $124 Price Target?
NASDAQ:TCRX

TScan Therapeutics - TCRX Short Interest Ratio & Short Volume

$1.79
+0.06 (+3.47%)
(As of 01/27/2023 08:56 PM ET)
Add
Compare
Today's Range
$1.68
$1.90
50-Day Range
$1.49
$2.35
52-Week Range
$1.45
$5.60
Volume
141,500 shs
Average Volume
415,083 shs
Market Capitalization
$43.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.00

TScan Therapeutics Short Interest Data

Current Short Volume
144,900 shares
Previous Short Volume
147,200 shares
Change Vs. Previous Month
-1.56%
Dollar Volume Sold Short
$318,780.00
Short Interest Ratio / Days to Cover
1.1
Last Record Date
January 15, 2023
Outstanding Shares
24,080,000 shares
Float Size
9,160,000 shares
Short Percent of Float
1.58%
Today's Trading Volume
141,500 shares
Average Trading Volume
415,083 shares
Today's Volume Vs. Average
-65.91%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling TScan Therapeutics ?

Sign up to receive the latest short interest report for TScan Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

TCRX Short Interest Over Time

TCRX Days to Cover Over Time

TCRX Percentage of Float Shorted Over Time


TScan Therapeutics (NASDAQ:TCRX) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/15/2023144,900 shares $318,780.00 -1.6%1.6%1.1 $2.20
12/30/2022147,200 shares $228,160.00 +1.1%1.6%5.8 $1.55
12/15/2022145,600 shares $276,640.00 -5.9%1.6%7.4 $1.90
11/30/2022154,800 shares $334,368.00 -3.9%1.7%8.5 $2.16
11/15/2022161,000 shares $431,480.00 +14.9%1.8%8.5 $2.68
10/31/2022140,100 shares $378,270.00 +151.5%1.5%7.3 $2.70
10/15/202255,700 shares $167,100.00 -7.0%0.6%2.6 $3.00
9/30/202259,900 shares $182,695.00 +12.6%0.7%3 $3.05
9/15/202253,200 shares $173,432.00 +731.3%0.6%2.5 $3.26
8/31/20226,400 shares $17,600.00 -96.8%0.1%0.3 $2.75
8/15/2022202,300 shares $681,751.00 +12.3%2.2%9.9 $3.37
7/31/2022180,200 shares $791,078.00 +8.8%2.0%1.9 $4.39
7/15/2022165,700 shares $565,037.00 +5.5%1.8%1.7 $3.41
6/30/2022157,000 shares $493,765.00 -0.2%1.7%1.5 $3.15
6/15/2022157,300 shares $493,922.00 +17.0%1.7%1.3 $3.14
5/31/2022134,500 shares $430,400.00 -41.9%1.5%1.1 $3.20
5/15/2022231,600 shares $576,684.00 +830.1%2.5%1.9 $2.49
4/30/202224,900 shares $53,535.00 +11.2%0.3%0.4 $2.15
4/15/202222,400 shares $58,912.00 +1.8%0.3%0.5 $2.63
3/31/202222,000 shares $61,600.00 +31.0%0.3%0.5 $2.80
3/15/202216,800 shares $60,648.00 -35.6%0.2%0.5 $3.61
2/28/202226,100 shares $109,620.00 -20.7%0.3%0.7 $4.20
2/15/202232,900 shares $177,660.00 -39.1%0.4%1 $5.40
1/31/202254,000 shares $260,820.00 -27.8%0.6%1.6 $4.83
1/15/202274,800 shares $377,740.00 -21.8%0.7%2.2 $5.05
12/31/202195,700 shares $430,650.00 -2.5%0.9%2.4 $4.50
12/15/202198,100 shares $485,595.00 +4.0%1.0%2.3 $4.95
11/30/202194,300 shares $722,338.00 +38.3%0.9%1.6 $7.66
11/15/202168,200 shares $554,466.00 +32.2%0.7%1 $8.13
10/29/202151,600 shares $452,016.00 +11.7%0.6%0.6 $8.76
10/15/202146,200 shares $311,850.00 -50.1%0.5%0.5 $6.75
9/30/202192,500 shares $771,450.00 +2,102.4%1.0%0.7 $8.34
9/15/20214,200 shares $28,854.00 -67.4%0.1%0 $6.87
8/31/202112,900 shares $114,681.00 -16.2%0.1%0.1 $8.89
8/13/202115,400 shares $158,928.00 No Change0.2%0.1 $10.32













TCRX Short Interest - Frequently Asked Questions

What is TScan Therapeutics' current short interest?

Short interest is the volume of TScan Therapeutics shares that have been sold short but have not yet been closed out or covered. As of January 15th, investors have sold 144,900 shares of TCRX short. 1.58% of TScan Therapeutics' shares are currently sold short. Learn More on TScan Therapeutics' current short interest.

What is a good short interest ratio for TScan Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TCRX shares currently have a short interest ratio of 1.0. Learn More on TScan Therapeutics's short interest ratio.

What is a good short interest percentage for TScan Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.58% of TScan Therapeutics' floating shares are currently sold short.

Is TScan Therapeutics' short interest increasing or decreasing?

TScan Therapeutics saw a drop in short interest during the month of January. As of January 15th, there was short interest totaling 144,900 shares, a drop of 1.6% from the previous total of 147,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is TScan Therapeutics' float size?

TScan Therapeutics currently has issued a total of 24,080,000 shares. Some of TScan Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. TScan Therapeutics currently has a public float of 9,160,000 shares.

How does TScan Therapeutics' short interest compare to its competitors?

1.58% of TScan Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to TScan Therapeutics: Achilles Therapeutics plc (0.20%), Cardiol Therapeutics Inc. (0.42%), Axcella Health Inc. (1.20%), BioCardia, Inc. (0.42%), AVROBIO, Inc. (0.35%), Dyadic International, Inc. (2.25%), IN8bio, Inc. (1.52%), Evaxion Biotech A/S (0.13%), Protara Therapeutics, Inc. (0.97%), and TRACON Pharmaceuticals, Inc. (1.67%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.43 billion), T. Rowe Price Group, Inc. ($2.26 billion), Coinbase Global, Inc. ($2.19 billion), Etsy, Inc. ($1.78 billion), Paramount Global ($1.77 billion), Old Dominion Freight Line, Inc. ($1.69 billion), United Rentals, Inc. ($1.53 billion), American Airlines Group Inc. ($1.52 billion), PG&E Co. ($1.48 billion), and Voya Financial, Inc. ($1.47 billion). View all of the most shorted stocks.

What does it mean to sell short TScan Therapeutics stock?

Short selling TCRX is an investing strategy that aims to generate trading profit from TScan Therapeutics as its price is falling. TCRX shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against TScan Therapeutics?

A short squeeze for TScan Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TCRX, which in turn drives the price of the stock up even further.

How often is TScan Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TCRX, twice per month. The most recent reporting period available is January, 15 2023.



This page (NASDAQ:TCRX) was last updated on 1/30/2023 by MarketBeat.com Staff